Received GSK royalties of $60.3 million, net product revenues of $11.5 million and license revenue of $8.0 million in the first quarter of 2023Repurchased $40.3 million of common stock and paid off $96.2 million of 2023 convertible notesBURLINGAME, Calif. (BUSINESS WIRE) Innoviva, Inc. (NASDAQ: INVA) (“Innoviva” o.
BURLINGAME, Calif. — BURLINGAME, Calif. — Innoviva Inc. on Tuesday reported profit of $34.9 million in its first quarter. The Burlingame, California-based company said it had. | May 9, 2023
Received GSK royalties of $60.3 million, net product revenues of $11.5 million and license revenue of $8.0 million in the first quarter of 2023
Repurchased $40.3 million of common stock and paid. | May 9, 2023
Form N-CSRS TRUST FOR PROFESSIONAL For: Feb 28 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Robeco Institutional Asset Management B.V. raised its holdings in Innoviva, Inc. (NASDAQ:INVA – Get Rating) by 0.3% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 520,899 shares of the biotechnology company’s stock after buying an additional 1,619 shares during the period. Robeco Institutional […]